Compare Edwards Lifesciences Corporation Common Stock (EW) vs Direxion NASDAQ 100 Equal Weighted Index Shares (QQQE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Direxion NASDAQ 100 Equal Weighted Index Shares — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Direxion NASDAQ 100 Equal Weighted Index Shares trades at $121.2 (market cap $1.47B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 33.6× Direxion NASDAQ 100 Equal Weighted Index Shares's market cap, and Direxion NASDAQ 100 Equal Weighted Index Shares is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | QQQE | |
|---|---|---|
Market Cap | $49.44B | $1.47B |
Volume | 3,508,027 | 181,648 |
Sector | Health | Broad Market / Factor |
52-Week High | $95.18 | $124.69 |
52-Week Low | $72.65 | $96.06 |
Enterprise Value | $45.90B | — |
Typical Hold Time | — | 47 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
QQQE (Direxion NASDAQ-100 Equal Weighted Index ETF) trades at $121.89, down 0.89% on the day. The ETF maintains a bullish technical outlook with strong moving average signals while oscillators show neutral momentum. Recent analysis highlights QQQE's advantage over traditional NASDAQ-100 ETFs due to its equal-weight approach, reducing technology concentration from 60% to 45% while maintaining exposure to large-cap growth stocks.
The equal-weight methodology provides diversification benefits amid tech sector volatility. Key risks include market concentration in growth stocks and broader market sentiment shifts. Recent analyst commentary suggests tactical opportunities in equal-weight strategies for the coming year, though investors should monitor sector rotation trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Direxion NASDAQ 100 Equal Weighted Index Shares
QQQE is an ETF that seeks to track the performance of the NASDAQ-100 Equal Weighted Index. Unlike traditional market-capitalization-weighted indexes, this fund assigns equal weight to each of the 100 non-financial companies in the NASDAQ-100 and rebalances quarterly. This equal-weighting scheme reduces concentration risk in the largest technology companies and increases the fund's exposure to smaller-cap and mid-cap companies within the index, providing a differentiated growth profile.
Read more on QQQE →
